02 9241 2158

info@sydneymedicalspecialists.com.au

News

 DR DAVID YEO

News 18.07.18

DR DAVID YEO

Dr David Yeo is an Upper Gastrointestinal, Hepatobiliary and Transplant Surgeon who works at Royal Prince Alfred (RPA) and St George Hospitals in Sydney. He also has appointments at St George Private Hospital, the Chris O’Brien Lifehouse Cancer Centre, Mater Hospital and Strathfield Private Hospital. Prior to commencing work in 2014, he completed four years of post-fellowship training at RPA Hospital in Sydney, Austin Hospital in Melbourne and St James’s University Hospital in Leeds, United Kingdom.

After completing a Bachelor of Medical Science degree at the University of Sydney, he went on to study Medicine graduating in 2002 with Honours. He undertook surgical training at both RPA and St George Hospitals obtaining his General Surgical Fellowship in 2009. David then spent the next two years of his post-fellowship training completing the Australian and New Zealand Hepato-Pancreato-Biliary Association Fellowship program based at RPA Hospital in Sydney and the Austin Hospital in Melbourne. In his fourth and final post-fellowship year he travelled to the United Kingdom to work at St James’s University Hospital where he learnt expertise in aggressive oncological liver resection and liver transplantation.

Academically, David completed a Master of Surgery in 2008 focusing on the impact of PET/CT imaging on the treatment of colorectal cancer liver metastases. He is the Clinical Research lead in Upper Gastrointestinal Surgery within the Institute of Academic Surgery at RPA Hospital.

David has broad clinical interests. Oncologically, he specialises in both primary and secondary liver tumours, stomach, pancreatic and biliary/gallbladder tumours. He performs an extensive range of non-cancer related operations for conditions such as gallstone disease, hernias and obesity. In addition, he is involved with medical device development aiming to improve the safety and effectiveness of current technologies. He was awarded a grant from the NSW government following completion of the ATP Innovation Medical Device Commercialisation Training Program.

Subscribe
to our newsletter

Stay informed on all the latest news and events.